ArticlePloS one2025
Risk factor analysis and establishment of a predictive model for epilepsy comorbid with depression.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Efficacy of psychological and behavioral interventions for depressive symptoms in people with epilepsy: a systematic review and meta-analysis.Frontiers in medicine · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to utilize our hospital's existing Stereo Electroencephalography (SEEG) examination results combined with other clinical data to systematically analyze the risk factors for epilepsy comorbid with depression, and to establish a model for predicting the risk of developing depression in epilepsy patients. Clinically, this model can be used to predict the risk of comorbid depression in epilepsy patients, thereby enhancing the identification of this condition and providing a theoretical basis for proactive intervention in depressive symptoms among epilepsy patients.
methodsA retrospective analysis was conducted on the clinical data of patients diagnosed with epilepsy in the Department of Neurosurgery at Tongde Hospital Of Zhejiang Province from 01/01/2020-31/12/2024, all of whom underwent Electroencephalography (EEG) examinations. According to the C-NDDI-E scores and clinical manifestations, the epilepsy patients were divided into an epilepsy with comorbid depression group (study group) and epilepsy without depression group (control group). Univariate analysis was performed using SPSS 26.0 software to screen for potential factors contributing to depression comorbid with epilepsy. Variables with a univariate P ≤ 0.05 were entered into a linear Lasso regression analysis. Those with statistical significance were then used to construct a nomogram model for predicting the risk of depression comorbid with epilepsy using R software.
resultsA total of 152 epilepsy patients were enrolled, including 43 in the study group and 109 in the control group. Univariate analysis showed statistically significant (P < 0.05) differences between the groups in terms of age, employment status, marital status, age of onset, frequency of epileptic seizures, type of drug treatment, scalp EEG-determined epileptogenic zone, SEEG-determined epileptogenic zone, and Activities of Daily Living (ADL) score. Lasso regression analysis revealed that marital status (p = 0.0008), Enrollment age (OR = 0.9152, P = 0.0003, 95% CI: 0.8673-0.9562), frequency of epileptic seizures (OR =5.9946, P = 0.0030, 95% CI: 1.8952-20.6541), type of drug treatment (OR = 44.4062, P = 0.0157, 95% CI: 1.3629-15.6702), SEEG results indicating the epileptogenic zone (hippocampal onset: OR = 12.3489, P = 0.0026, 95% CI: 2.5902-70.9811), and ADL score (OR = 0.9358, P = 0.0314, 95% CI: 0.8785-0.9930) were independent risk factors for depression comorbid with epilepsy. The area under the ROC curve (AUC) was 0.895, indicating strong discriminative ability and high predictive accuracy.
conclusionIndependent risk factors for depression comorbid with epilepsy include: hippocampal origin of epilepsy as identified by SEEG, unstable marital status, younger age at the time of enrollment, higher frequency of epileptic seizures (>4 times/month), use of specific anti-seizure medications (such as topiramate, phenobarbital, levetiracetam, and perampanel), and lower activities of daily living (ADL) scores. The nomogram model established based on these factors performs well in relatively accurately predicting the risk of depression comorbid with epilepsy. This facilitates early identification of high-risk patients in clinical practice, enabling timely interventions to prevent the severe consequences of depressive episodes, improving patient adherence to epilepsy treatment, and emphasizing the link between psychological and neuroscientific aspects in epilepsy management to foster interdisciplinary collaboration for more comprehensive patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.